
7.08 Delayed Data As of May 20 | ![]() Today’s Change | 4.81 Today|||52-Week Range 8.65 | +4.58% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 9.00. The median estimate represents a +69.49% increase from the last price of 7.08.
The current consensus among 5 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.